ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025

Discovery of an APP-selective BACE1 inhibitor for Alzheimer's disease.

Jesus Campagna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.